Benedetta Bolognesi Archives - Page 3 of 4 - Institute for Bioengineering of Catalonia

December 15, 2022December 14, 2022

A new atlas unveils which mutations are behind the noxious amyloid formation

Researchers from the Institute for Bioengineering of Catalonia (IBEC) have developed the most complete atlas up to date of the genetic mutations that cause the formation of amyloid beta fibril, … Read more

October 4, 2022September 14, 2022

Science and Art: IBEC collaborates on a work by Antoni Muntadas at Ars Electronica 2022

When is a living organism considered extinct? This is one of the fundamental questions of the artwork presented at Ars Electronica 2022 by Antoni Muntadas, a Catalan artist based in … Read more

October 28, 2022July 19, 2022

Postdoctoral researcher at the Protein Phase Transitions in Health and Disease Research group

Ref: Postdoctoral / Deadline: 24th August

October 28, 2022July 18, 2022

Lab Technician at the Protein phase transitions in health and disease Research Group

Ref: Lab Technician / Deadline: 29th July 2022

July 22, 2021July 21, 2021

Benedetta Bolognesi and Ben Lehner win competitive funding to join forces against neurodegenerative diseases

The “la Caixa” Foundation will fund a large and innovative research project co-led by IBEC Junior Group Leader Benedetta Bolognesi and by ICREA research professor Ben Lehner at CRG, which aims to gain a better understanding of the genetic causes leading to neurodegenerative diseases. Researchers will combine deep mutagenesis and machine learning techniques to produce a “map of dementia” as a method to predict whether a person is more susceptible to suffer these diseases.

June 29, 2021June 28, 2021

IBEC researchers win two “BIST Ignite Seed Grants”

IBEC researchers receive two “Ignite Seed Grants” to combine their skills with other BIST members to seek scientific answers to health challenges. Benedetta Bolognesi will study, with the IRB, Huntington’s disease and other neurodegenerative pathologies without treatment. On the other hand, Juan Manuel Fernández-Costa and researchers at ICFO will develop muscles-on-a-chip and biomagnetism sensors to accelerate the design of new treatments for muscular dystrophy.

March 22, 2021March 15, 2021

One more step towards early detection of Alzheimer’s

Benedetta Bolognesi, junior group leader at IBEC, appears in different media for a recent study published in the eLife magazine. In the study they show the first map with all the possible mutations in the amyloid beta peptide and tested how they influence its aggregation into plaques, a pathological hallmark of Alzheimer’s disease.

March 9, 2021March 9, 2021

First comprehensive map of amyloid plaque mutations opens new avenues for early detection of Alzheimer’s disease

A study published in the journal eLife made all the possible mutations in the amyloid beta peptide and tested how they influence its aggregation into plaques, a pathological hallmark of Alzheimer’s disease.

November 13, 2020September 10, 2020

Benedetta Bolognesi featured at “Maldita Ciencia” talking about coronavirus

Benedetta Bolognesi, group leader at IBEC has been collaborating with “Maldita Ciencia” to clarify doubts and rumours about Covid-19″.

November 13, 2020May 26, 2020

IBEC receives a visit from the Mayor of Barcelona interested in our research against Covid19

The Mayor of Barcelona, Ada Colau, visited IBEC facilities last Friday to learn, by our Director and a group of researchers, how bioengineering can help find solutions to health problems such as COVID19, cancer, or degenerative diseases.

When in early 2020, more than 200 scientists gathered in La Pedrera in Barcelona to discuss the present and future of bioengineering, no one imagined that the world would experience the first pandemic of the 21st century and that science would take on more importance than ever.